Nickel allergy can result in both cutaneous and systemic manifestations, and can range from mild to severe symptoms. A severe form of this allergy is the Systemic nickel allergy syndrome, clinically characterized by cutaneous manifestions (contact dermatitis, pompholyx, hand dermatitis dyshydrosis, urticaria) with chronic course and systemic symptoms (headache, asthenia, itching, and gastrointestinal disorders related to histopathological alterations of gastrointestinal mucosa, borderline with celiac disease). This review aims to briefly update the reader on past and current therapies for nickel contact allergy.
UsatineRP, RiojasM. Diagnosis and management of contact dermatitis. Am Fam Physician, 2010; 82:249-55.
3.
ThyssenJP, MennéT. Metal allergy—a review on exposures, penetration, genetics, prevalence, and clinical implications. Chem Res Toxicol, 2010; 23:309-18, doi: 10.1021/tx9002726.
4.
TammaroA, PersechinoS, De MarcoG, et al.Allergy to nickel: first results on patients administered with an oral hyposensitization therapy. Int J Immunopathol Pharmacol, 2009; 22:837-40.
5.
RobertsonL.New and existing therapeutic options for hand eczema. Skin Ther Lett, 2009; 14:1-5.
6.
PelfiniC, VigniniM, DesirelloG. Use and abuse of topical corticosteroids in general practice. G Ital Dermatol Venereol, 1984; 119:75-88.
HachemJP, De PaepeK, VanpeeE, et al.The effect of two moisturisers on skin barrier damage in allergic contact dermatitis. Eur J Dermatol, 2002; 12:136-8.
9.
HachemJP, De PaepeK, VanpéE, et al.Efficacy of topical corticosteroids in nickel-induced contact allergy. Clin Exp Dermatol, 2002; 27:47-50, doi: 10.1046/j.0307-6938.2001.00963.x.
10.
PacorML, Di LorenzoG, MartinelliN, et al.Tacrolimus ointment in nickel sulphate-induced steroid-resistant allergic contact dermatitis. Allergy Asthma Proc, 2006; 27:527-31, doi: 10.2500/aap.2006. 27.2915.
11.
KorfitisC, GregoriouS, RallisE, RigopoulosD. Pimecrolimus versus topical corticosteroids in dermatology. Expert Opin Pharmacother, 2007; 8:1565-73, doi: 10.1517/14656566.8.10.1565.
12.
DraelosZD.Use of topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas. Curr Med Res Opin, 2008; 24:985-94, doi: 10.1185/030079908X280419.
13.
WerfelT.Topical use of pimecrolimus in atopic dermatitis: update on the safety and efficacy. J Dtsch Dermatol Ges, 2009; 7:739-42.
14.
SantucciB, CristaudoA, MehrabanM, et al.ZnSO4 treatment of NiSO4-positive patients. Contact Dermatitis, 1999; 40:281-2, doi: 10.1111/j.1600-0536.1999.tb06066.x.
15.
WeissmannK, MennéT.Nickel allergy and drug interaction. In: MaibachHI, MennéT, editors. Nickel and the skin: immunology and toxicology. Boca Raton: CRC Press Inc; 1989. p. 179-86.
16.
BiegoGH, JoyeuxM, HartemannP, DerbryG. Daily intake of essential minerals and metallic micropollutants from foods in France. Sci Total Environ, 1998; 217:27-36, doi: 10.1016/S0048-9697(98)00160-0.
17.
JensenCS, MennéT, JohansenJD. Systemic contact dermatitis after oral exposure to nickel: a review with a modified meta-analysis. Contact Dermatitis, 2006; 54:79-86, doi: 10.1111/j.0105-1873.2006.00773.x.
18.
MinelliM, SchiavinoD, MuscaF, et al.Oral hyposensitization to nickel induces clinical improvement and a decrease in TH1 and TH2 cytokines in patients with systemic nickel allergy syndrome. Int J Immunopathol Pharmacol, 2010; 23:193-201.
19.
KaaberK, MennéT, VeienN. Antabuse treatment of nickel dermatitis. Chelation—a new principle in the treatment of nickel dermatitis. Contact Dermatitis, 1979; 5:221-8, doi: 10.1111/j.1600-0536.1979.tb04855.x.
20.
MennéT, KaaberK, TjellJC. Treatment of nickel dermatitis. (The influence of tetraethylthiuramdisulfide (Antabuse) on nickel metabolism.) Ann Clin Lab Sci, 1980; 10:160-4.
21.
ChristensenJD.Disulfiram treatment of three patients with nickel dermatitis. Contact Dermatitis, 1982; 8:105-8, doi: 10.1111/j.1600-0536.1982.tb04154.x.
22.
KaaberK, MennéT, VeienN, HougaardP. Treatment of nickel dermatitis with Antabuse: a double blind study. Contact Dermatitis, 1983; 9:297-9, doi: 10.1111/j.1600-0536.1983.tb04394.x.
23.
HopferSM, LindenJV, RezukeWN, et al.Increased nickel concentrations in body fluids of patients with chronic alcoholism during disulfiram therapy. Res Commun Chem Pathol Pharmacol, 1987; 55:101-9.
24.
SharmaAD.Disulfiram and low nickel diet in the management of hand eczema: a clinical study. Indian J Dermatol Venereol Leprol, 2006; 72:113-8, doi: 10.4103/0378-6323.25635.
25.
ArtikS, HaarhuisK, WuX, et al.Tolerance to nickel: oral nickel administration induces a high frequency of anergic T cells with persistent suppressor activity. J Immunol, 2001; 167:6794-803.
26.
BagotM, CharueD, FlechetML, et al.Oral desensitization in nickel allergy induces a decrease in nickel-specific T-cells. Eur J Dermatol, 1995; 5:614-27.
27.
Van HoogstratenIMW, BoosC, BodenD, et al.Oral induction of tolerance to nickel sensitization in mice. J Invest Dermatol, 1993; 101:26-31, doi: 10.1111/1523-1747.ep12358502.
28.
Van HoogstratenIMW, De GrootJ, BodenD, et al.Development of a concomitant nickel and chromium sensitization model in the guinea pig. Int Arch Allergy Immunol, 1992; 97:258-366, doi: 10.1159/000236131.
29.
SjovallP, ChristensenOB, MollerH. Oral hyposensitization in nickel allergy. J Am Acad Dermatol, 1987; 17:774-8, doi: 10.1016/S0190-9622(87)70262-X.
30.
FalagianiP.Nickel hyposensitization: a literature review. Int J Immunopathol Pharmacol, 2005 Oct-Dec;18(4 Suppl):3-5.
31.
CzarnobilskaE, ObtulowiczK, WsolekK, et al.[Mechanisms of nickel allergy]. Przegl Lek, 2007; 64:502-5.
32.
SchiavinoD, NuceraE, PatriarcaG. A clinical trial of oral hyposensitization in systemic allergy to nickel. Int J Immunopathol Pharmacol, 2006; 19:593-600.
